{"data":{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:32372307", "kind": "science-record", "revision": 6, "content_hash": "sha256:17442b545625bbc5fb2ca8e43b26fb19ba8f74792b33aead768d0b5b94fd6434", "created_at": "2026-11-01T15:41:00Z", "updated_at": "2026-11-01T21:23:11Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Integrative bioinformatics analysis reveals miR-494 and its target genes as predictive biomarkers of trastuzumab-resistant breast cancer.", "doi": "10.1186/s43046-020-00028-2", "pmid": "32372307", "authors": ["Adam Hermawan", "Herwandhani Putri"], "journal": "Journal of the Egyptian National Cancer Institute", "year": 2020, "abstract": "BACKGROUND: The focus of trastuzumab resistance biomarkers in recent decades has been on epigenetic and non-coding RNA-based mechanisms. In this study, the potential of miR-494 and its target genes as predictive biomarkers for breast cancer (BC) resistance to trastuzumab was identified. The microarray data were obtained from the GEO database, including GSE101841, GSE75669, and GSE66305. Data processing was conducted using GEO2R to obtain differentially expressed genes (DEGs).\nRESULTS: The data analysis using GEO2R revealed that DEGs from GSE101841 and GSE75669 consisted of 3 and 135 upregulated miRNAs, respectively. On the other hand, the same analysis revealed 8 and 226 downregulated miRNAs for DEGs from GSE101841 and GSE75669, respectively. A Venn diagram showed that one miR was detectable in serum and tissue samples, namely miR-494. The miR-494 target was predicted using the miRecords database and resulted in 69 target genes. A Venn diagram between miR-494 target genes from miRecords and the mRNA array from GSE66305 revealed three potential targets of CNR1, RBM39, and ZNF207. A Kaplan-Meier survival plot showed that BC patients with a high miR-494 level and a low ZNF207 mRNA level had significantly worse overall survival. Validation of target genes in BC samples and trastuzumab-resistant and -sensitive BC cells with GEPIA and ONCOMINE highlighted the potential of CNR1, RBM39, and ZNF207 as predictive biomarkers of trastuzumab resistance in BC cells.\nCONCLUSION: Taken together, these results suggest that miR-494 plays a role in the mechanism of BC resistance to trastuzumab by involving its target genes CNR1, RBM39, and ZNF207.", "claims": [{"id": "claim-method", "statement": "The prognostic value of miR-494 and the target genes (CNR1, RBM39, and ZNF207) was evaluated using Kaplan–Meier survival curves (http://kmplot.com) and the log-rank test.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32372307", "locator": "sections[5] \"Kaplan–Meier survival analysis\" paragraph 2", "quote": "The prognostic value of miR-494 and the target genes (CNR1, RBM39, and ZNF207) was evaluated using Kaplan–Meier survival curves (http://kmplot.com) and the log-rank test."}], "state": "complete"}, {"id": "claim-data-access", "statement": "All data generated or analyzed during this study are included in this published article [and its supplementary information files].", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32372307", "locator": "sections[20] \"Availability of data and materials\" paragraph 2", "quote": "All data generated or analyzed during this study are included in this published article [and its supplementary information files]."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:32372307"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE101841"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE101841"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:32372307", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s43046-020-00028-2", "sha256": "sha256:d42170deceb99b95995b34468152897123f2ab7809ea7f81b08edde6dd3c2e13", "bytes": 27322, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s43046-020-00028-2", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC13317115", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE101841", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE101841", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE101841", "version": null, "note": "All data generated or analyzed during this study are included in this published article [and its supplementary information files].", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All data generated or analyzed during this study are included in this published article [and its supplementary information files].", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM2717023", "GSM2717024", "GSM2717025", "GSM2717026", "GSM2717027", "GSM2717028", "GSM2717029", "GSM2717030", "GSM2717031", "GSM2717032", "GSM2717033", "GSM2717034", "GSM2717035", "GSM2717036", "GSM2717037", "GSM2717038", "GSM2717039", "GSM2717040", "GSM2717041", "GSM2717042", "GSM2717043", "GSM2717044", "GSM2717045", "GSM2717046", "GSM2717047", "GSM2717048", "GSM2717049", "GSM2717050", "GSM2717051", "GSM2717052", "GSM2717053", "GSM2717054", "GSM2717055", "GSM2717056", "GSM2717057", "GSM2717058", "GSM2717059", "GSM2717060", "GSM2717061", "GSM2717062", "GSM2717063", "GSM2717064", "GSM2717065", "GSM2717066", "GSM2717067", "GSM2717068", "GSM2717069", "GSM2717070", "GSM2717071", "GSM2717072", "GSM2717073", "GSM2717074", "GSM2717075", "GSM2717076", "GSM2717077", "GSM2717078", "GSM2717079", "GSM2717080", "GSM2717081", "GSM2717082", "GSM2717083", "GSM2717084", "GSM2717085", "GSM2717086", "GSM2717087", "GSM2717088", "GSM2717089", "GSM2717090", "GSM2717091", "GSM2717092", "GSM2717093", "GSM2717094", "GSM2717095", "GSM2717096", "GSM2717097", "GSM2717098", "GSM2717099", "GSM2717100", "GSM2717101", "GSM2717102", "GSM2717103", "GSM2717104", "GSM2717105", "GSM2717106", "GSM2717107", "GSM2717108", "GSM2717109", "GSM2717110", "GSM2717111", "GSM2717112", "GSM2717113", "GSM2717114", "GSM2717115", "GSM2717116", "GSM2717117", "GSM2717118", "GSM2717119", "GSM2717120", "GSM2717121", "GSM2717122", "GSM2717123", "GSM2717124", "GSM2717125"], "sample_count": 103, "group_sizes": null, "group_sizes_basis": null, "platform": "23138", "taxon": "Homo sapiens", "title": "Serum microRNA profile of Her2 positive metastatic breast cancer patients", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE66305", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE66305", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE66305", "version": null, "note": "All data generated or analyzed during this study are included in this published article [and its supplementary information files].", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All data generated or analyzed during this study are included in this published article [and its supplementary information files].", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1619387", "GSM1619388", "GSM1619389", "GSM1619390", "GSM1619391", "GSM1619392", "GSM1619393", "GSM1619394", "GSM1619395", "GSM1619396", "GSM1619397", "GSM1619398", "GSM1619399", "GSM1619400", "GSM1619401", "GSM1619402", "GSM1619403", "GSM1619404", "GSM1619405", "GSM1619406", "GSM1619407", "GSM1619408", "GSM1619409", "GSM1619410", "GSM1619411", "GSM1619412", "GSM1619413", "GSM1619414", "GSM1619415", "GSM1619416", "GSM1619417", "GSM1619418", "GSM1619419", "GSM1619420", "GSM1619421", "GSM1619422", "GSM1619423", "GSM1619424", "GSM1619425", "GSM1619426", "GSM1619427", "GSM1619428", "GSM1619429", "GSM1619430", "GSM1619431", "GSM1619432", "GSM1619433", "GSM1619434", "GSM1619435", "GSM1619436", "GSM1619437", "GSM1619438", "GSM1619439", "GSM1619440", "GSM1619441", "GSM1619442", "GSM1619443", "GSM1619444", "GSM1619445", "GSM1619446", "GSM1619447", "GSM1619448", "GSM1619449", "GSM1619450", "GSM1619451", "GSM1619452", "GSM1619453", "GSM1619454", "GSM1619455", "GSM1619456", "GSM1619457", "GSM1619458", "GSM1619459", "GSM1619460", "GSM1619461", "GSM1619462", "GSM1619463", "GSM1619464", "GSM1619465", "GSM1619466", "GSM1619467", "GSM1619468", "GSM1619469", "GSM1619470", "GSM1619471", "GSM1619472", "GSM1619473", "GSM1619474"], "sample_count": 88, "group_sizes": null, "group_sizes_basis": null, "platform": "570", "taxon": "Homo sapiens", "title": "Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with chemotherapy plus trastuzumab and lapatinib as neoadjuvant therapy for HER2-positive breast cancer [expression]", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE75669", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75669", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE75669", "version": null, "note": "All data generated or analyzed during this study are included in this published article [and its supplementary information files].", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All data generated or analyzed during this study are included in this published article [and its supplementary information files].", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1963127", "GSM1963128", "GSM1963129", "GSM1963130", "GSM1963131", "GSM1963132", "GSM1963133", "GSM1963134", "GSM1963135", "GSM1963136", "GSM1963137", "GSM1963138", "GSM1963139", "GSM1963140", "GSM1963141", "GSM1963142", "GSM1963143", "GSM1963144", "GSM1963145", "GSM1963146", "GSM1963147", "GSM1963148", "GSM1963149", "GSM1963150", "GSM1963151", "GSM1963152", "GSM1963153", "GSM1963154", "GSM1963155", "GSM1963156", "GSM1963157", "GSM1963158", "GSM1963159", "GSM1963160", "GSM1963161", "GSM1963162", "GSM1963163", "GSM1963164", "GSM1963165", "GSM1963166", "GSM1963167", "GSM1963168", "GSM1963169", "GSM1963170", "GSM1963171", "GSM1963172", "GSM1963173", "GSM1963174", "GSM1963175", "GSM1963176", "GSM1963177", "GSM1963178", "GSM1963179", "GSM1963180"], "sample_count": 54, "group_sizes": null, "group_sizes_basis": null, "platform": "7731", "taxon": "Homo sapiens", "title": "miRNAs Expression of Mexican Patients with Breast Cancer", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:32372307:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:29f468ad50c17815ba912f9dae867456475d881ce05d7a66949f0e952eebf481", "bytes": 802, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[9]/table-wrap[1]#Tab1", "version": null, "note": "Description of GSE datasets", "structure": {"pmcid": "PMC13317115", "section_index": 3, "section_title": "Data collection and processing", "row_count": 4, "column_count": 5}, "table": {"label": "Table 1", "caption": "Description of GSE datasets", "rows": [["Accession code", "Sample", "Number of samples", "Type of RNA", "References"], ["GSE101841", "Serum of tastuzumab-treated patients in China", "61 sensitive to trastuzumab, 42 resistance to trastuzumab", "miRNA", "[20]"], ["GSE75669", "Breast tumor from Mexican patients treated with trastuzumab", "4 samples from patient with complete response, 4 samples from patients with partial, progressives and poor response to trastuzumab", "miRNA", "[21]"], ["GSE66305", "Breast tumor from Italian patients treated with trastuzumab", "5 samples from patients with complete response, and 18 patients with partial response to trastuzumab", "mRNA", "[22]"]], "row_count": 4, "column_count": 5, "numeric_cells": 9, "header_rows": 1, "locator": "section[9]/table-wrap[1]#Tab1"}}, {"id": "asset:table:pmid:32372307:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:29f468ad50c17815ba912f9dae867456475d881ce05d7a66949f0e952eebf481", "bytes": 802, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[9]/table-wrap[1]#Tab1", "version": null, "note": "Description of GSE datasets", "structure": {"pmcid": "PMC13317115", "section_index": 9, "section_title": "Data collection and processing", "row_count": 4, "column_count": 5}, "table": {"label": "Table 1", "caption": "Description of GSE datasets", "rows": [["Accession code", "Sample", "Number of samples", "Type of RNA", "References"], ["GSE101841", "Serum of tastuzumab-treated patients in China", "61 sensitive to trastuzumab, 42 resistance to trastuzumab", "miRNA", "[20]"], ["GSE75669", "Breast tumor from Mexican patients treated with trastuzumab", "4 samples from patient with complete response, 4 samples from patients with partial, progressives and poor response to trastuzumab", "miRNA", "[21]"], ["GSE66305", "Breast tumor from Italian patients treated with trastuzumab", "5 samples from patients with complete response, and 18 patients with partial response to trastuzumab", "mRNA", "[22]"]], "row_count": 4, "column_count": 5, "numeric_cells": 9, "header_rows": 1, "locator": "section[9]/table-wrap[1]#Tab1"}}], "gaps": ["asset:data:geo:GSE101841 not downloaded", "asset:data:geo:GSE101841 licence not read", "asset:data:geo:GSE66305 not downloaded", "asset:data:geo:GSE66305 licence not read", "asset:data:geo:GSE75669 not downloaded", "asset:data:geo:GSE75669 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "The prognostic value of miR-494 and the target genes (CNR1, RBM39, and ZNF207) was evaluated using Kaplan–Meier survival curves (http://kmplot.com) and the log-rank test."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["logrank_test"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: log_rank_test."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE101841", "GSE75669", "GSE66305"], "resolved_accessions": ["GSE101841", "GSE75669", "GSE66305"], "statements": ["All data generated or analyzed during this study are included in this published article [and its supplementary information files]."], "basis": "The paper names GSE101841, GSE75669, GSE66305 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["logrank_test"], "assets": ["source:pmid:32372307", "data:geo:GSE101841", "asset:table:pmid:32372307:1", "asset:table:pmid:32372307:2"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE101841"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:20:12Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 22805, "completion_tokens": 3942, "cached_tokens": 791}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:32372307", "type": "paper", "label": "pmid:32372307"}, {"id": "source:pmid:32372307", "type": "manuscript", "label": "PMID 32372307 full text"}, {"id": "data:geo:GSE101841", "type": "dataset", "label": "GEO GSE101841"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:32372307", "type": "paper", "label": "pmid:32372307"}, {"id": "source:pmid:32372307", "type": "manuscript", "label": "PMID 32372307 full text"}, {"id": "data:geo:GSE101841", "type": "dataset", "label": "GEO GSE101841"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-32372307", "type": "extraction", "used": ["source:pmid:32372307"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE101841", "type": "accession_resolution", "used": ["data:geo:GSE101841"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:32372307", "parent_hash": "sha256:f0b7d1b8fa3d58a739e4a9f047690c649b204a939b8cea383611351dd3193268", "fork_of": null, "generation": 5}, "gaps": ["asset:data:geo:GSE101841 licence not read", "asset:data:geo:GSE101841 not downloaded", "asset:data:geo:GSE66305 licence not read", "asset:data:geo:GSE66305 not downloaded", "asset:data:geo:GSE75669 licence not read", "asset:data:geo:GSE75669 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["esistance to trastuzumab was identified. The microarray data were obtained from the GEO database, in", "NCOMINE (https://www.oncomine.org), a cancer microarray database, and web-based data-mining platform"], "order_basis": "paper_text_order:385", "id": "assay:1"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["logrank_test"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["The prognostic value of miR-494 and the target genes (CNR1, RBM39, and ZNF207) was evaluated using Kaplan–Meier survival curves (http://kmplot.com) and the log-rank test."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]},"meta":{"api_version":"v1","automation_ladder_snapshot":"ba34b49490d9bfaf","automation_ladder_caveats":["Method extraction is rule-based and has no hand-judged accuracy sample. Evidence bands order textual support; method agreement intervals are null (n=0), never probabilities. Work-type validation does not validate methods.","Operation coverage describes only explicitly named methods. It does not prove a complete protocol, compatible parameters, successful compilation or re-execution. Unrecognised or ambiguous methods require review.","Data reachability is a textual accession or public-data statement. No dataset was downloaded or checked for access, completeness or licence.","Capabilities are planning states seeded from the dated equipment register. No bench ownership, completed quote or partner booking is inferred. Procurement counts are dependencies, not guaranteed replications or financial returns.","Tier and blocker counts are deterministic assessments of this corpus, not measured agreement. R3 is reserved for procurement; unresolved methods and data require human work (R4). The most restrictive axis wins, with capability, method, data as tie-breaks. Resolving one blocker can leave another at the same tier."],"engine":"corpus_engine","engine_provider":"rule_based_v1+lex99e1195c7d6f","run_id":"run-20261023T122449232913","source":"esearch","source_detail":"PubMed mirror biomed_pubmed (read-only)","run_status":"complete","imported_at":"2026-11-03T20:16:52+00:00","generated_at":"2026-11-04T00:31:19+00:00","total_papers":5529,"total_assays_tracked":29,"automatable_assay_families":6,"validated":true,"caveat_count":9,"blocking_caveats":5,"caveats":[{"code":"low_evidence_dominates","basis":["4,152 of 5,529 classifications (75.1%) matched no cue evidence and sit at the 0.05 floor.","34 of 230 data_only calls (14.8%) are in that group."],"claim":"Work type and confidence bands","gloss":"Most records were classified from their title and framing alone, with assay-cue coverage at zero.","detail":"Most classifications in this run rest on no matched evidence at all. At the evidence floor the work type comes from title framing and a fixed prior, not from anything in the paper, so the published work-type split should be read as a rough triage signal rather than a measured distribution. The impact is bounded but not removed: since 2026-10-23 the engine excludes floor-confidence records from the shortlist entirely and publishes them separately as held out, so the recommendation is unaffected even though the census is.","status":"unverified","severity":"high"},{"code":"runtime_is_modelled","basis":["Runtime is summed from published per-assay hour figures. Timing awaits the first executed replication.","4,407 of 5,529 records (79.7%) model to 0.00 hours because no assay was matched, which the ranking then reads as \"cheapest\".","0 of 10 shortlisted records carry a 0.00-hour estimate."],"claim":"Estimated replication runtime","gloss":"The hour figures are estimates built from assay mentions; timing awaits the first executed replication.","detail":"The hour figures are a cost model derived from the bench steps implied by each matched assay family. The first executed replication will supply measured timing. Records without an assay match currently receive a zero-hour model value.","status":"unverified","severity":"high"},{"code":"signal_score_without_citations","basis":["5,529 of 5,529 records (100.0%) have no citation count from the source metadata."],"claim":"Signal score","gloss":"The signal score uses publication-type weight because the mirror supplied zero citation counts.","detail":"The source supplied no citation counts for any record in this run, so the signal score is publication-type weight only. The citation term of the ranking is inert here, and the shortlist is ordered by publication type alone.","status":"unverified","severity":"high"},{"code":"abstract_absent","basis":["1,667 of 5,529 records (30.2%) carry no abstract at all."],"claim":"Evidence base for classification","gloss":"Some records contain a title and publication type only, defining the available classification evidence.","detail":"Where the mirror contains a title and publication types only, those fields define the classifier evidence. A methods section is required for fuller automated and human review.","status":"unverified","severity":"medium"},{"code":"classifier_agreement_measured","basis":["Published two-way decision agreement 77.7% (310 of 399 decidable records) from a stratified hand-check of 438 real records.","Three-way diagnostic agreement 73.9% (288 of 390 decidable records).","data_only agreement 75.2% (100 of 133 decidable).","48 record(s) could not be decided from title and abstract and were excluded from the denominator.","56 analysis-only records were published under another work type, so the data_only share is not an upper bound."],"claim":"Published automatable decision","gloss":"This figure has been checked against a human reading the same papers, so we know how often it is right.","detail":"The published automatable / not-automatable distribution comes from a rule-based classifier that was hand-checked against a fixed ground-truth definition. The agreement rates below are measured, not estimated. The three-way work type remains a diagnostic and is reported separately.","status":"measured","severity":"high"},{"code":"llm_comparison_not_measured","basis":["rule_based_v1+lex99e1195c7d6f produced 5,529 of 5,529 classifications.","Measured on 438 labelled records; these are RULE-BASED figures, not model results."],"claim":"Rule-based versus LLM agreement","gloss":"Every number here is the rule engine’s own. Model comparison begins when a working API credential is connected and measured.","detail":"The published two-way decision agreed with a human reading on 310 of 399 decidable records (77.7%). The diagnostic three-way label agreed on 288 of 390 decidable records (73.9%). Every percentage in this run belongs to the rule engine. Model comparison begins when a working API credential is connected and measured.","status":"not_measured","severity":"high"},{"code":"confidence_is_a_band","basis":["low band: 135 of 210 hand-judged records were correct, 64.3% [57.6, 70.5] (95% CI).","medium band: 80 of 104 hand-judged records were correct, 76.9% [68.0, 84.0] (95% CI).","high band: 73 of 76 hand-judged records were correct, 96.0% [89.0, 98.7] (95% CI).","A fitted calibrated probability was built, measured and withdrawn: it overstated held-out accuracy and reorders nothing."],"claim":"Confidence band and evidence score","gloss":"The confidence band carries a measured accuracy interval; 0.85 represents relative rank strength.","detail":"Confidence on this run is a BAND plus its measured accuracy interval. The number stored alongside each record is a monotone evidence score that orders records; 0.85 represents relative rank strength. A fitted probability was withdrawn after it overstated held-out accuracy. Threshold on the band.","status":"measured","severity":"medium"},{"code":"three_way_split_is_diagnostic","basis":["The corpus is published at the two-way decision: automatable or not-automatable. The three-way split (data_only / physical / mixed) is published as a diagnostic with its measured reliability attached, not as a claim, because the rule engine's `mixed` call cannot be defended.","The engine called 22 record(s) mixed; 10 matched the human judgement (45.5%, 95% CI 26.9-65.3).","The engine's `mixed` call is right on 10/22 hand-judged records (45.5%, 95% CI 26.9%-65.3%); a constant `physical` guess scores 36.4%.","The engine's `mixed` call does not reliably beat a constant `physical` guess on the hand-judged records it labels mixed.","The sign of that difference flips between two independent samples, so the three-way refinement is not demonstrably informative.","The mixed stratum contributes a disproportionate share of errors relative to its size.","At title-only depth the physical/mixed split collapses: a title says that work was done, not whether it was also analysed."],"claim":"The published decision is two-way","gloss":"The three-way split is shown for diagnosis only. The published split is two ways.","detail":"Count and filter the corpus on automatable versus not-automatable. The data_only / physical / mixed split remains an internal engine diagnostic because the mixed call has lower measured reliability.","status":"measured","severity":"medium"},{"code":"automatable_flag_unproven","basis":["6 of 29 assay families are marked automatable now: meta_analysis, machine_learning, survival_analysis, pca, molecular_docking, differential_expression.","The flag is a rule over assay family and work type; validation begins with the first executed replication.","It inherits the 75.2% data_only agreement rate, because the flag requires the record to be analysis-only."],"claim":"Automatable now","gloss":"This flag marks assay families the rules classify as data-only. The first executed replication will validate it.","detail":"This flag marks families the rules consider replicable from data alone. Its validity depends on the analysis-only classification and will be measured through an executed replication.","status":"unverified","severity":"medium"}],"confidence_policy":"band_with_measured_interval","confidence_contract":{"policy":"band_with_measured_interval","summary":"Confidence is reported as a BAND with a measured accuracy interval. The raw evidence score supplies monotone ordering. A fitted point estimate was withdrawn after it overstated held-out accuracy.","evidence_score":"A monotone evidence score in [0,1] built from cue mass, axis separation and text coverage. Use it to order records. Interpret 0.85 as relative rank strength.","confidence_band":"low | medium | high. Consumers threshold on this value.","band_accuracy":"Wilson 95% interval on the measured agreement of the hand-judged records in this band.","calibrated_confidence":"WITHDRAWN. Reintroduction requires held-out evidence demonstrating reliable estimates across every bin."},"band_accuracy":{"low":{"n":210,"low":0.576,"band":"low","high":0.7046,"agree":135,"accuracy":0.6429},"high":{"n":76,"low":0.8903,"band":"high","high":0.9865,"agree":73,"accuracy":0.9605},"medium":{"n":104,"low":0.6795,"band":"medium","high":0.8397,"agree":80,"accuracy":0.7692}},"provider":"rule_based_v1+lex99e1195c7d6f","lexicon_id":"99e1195c7d6f","contract_published_at":"2026-10-23T12:25:29.022232+00:00","confidence_is_band":true,"confidence_is_probability":false,"decision_taxonomy":"two_way","decidable_fraction_two_way":0.8854,"decidable_fraction_two_way_low":0.8565,"decidable_fraction_two_way_high":0.9143,"decidable_fraction_three_way":0.8586,"decidable_fraction_three_way_low":0.8287,"decidable_fraction_three_way_high":0.8884,"decidable_population":5529,"validation_sample_size":438,"three_way_cost_fraction":0.0268,"three_way_cost_records":148,"decision_counts":{"automatable":230,"not_automatable":5299},"decision_split":{"automatable":{"count":230,"share":0.04159884246699222},"not_automatable":{"count":5299,"share":0.9584011575330078}},"diagnostic_work_type_counts":{"mixed":24,"physical":5275,"data_only":230}}}